Recently, Brock et al. have shown that treatment with antagomiR-20a restores the levels of BMPR2 in pulmonary arteries and prevents vascular remodeling in hypoxia-induced PAH [72]. This evidence concerns the gene BMPR2 and pulmonary arterial hypertension.